| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 33 |
| 1 | METHOTREXATE | 32 |
| 2 | FUROSEMIDE | 22 |
| 3 | CYTARABINE | 19 |
| 4 | CYCLOPHOSPHAMIDE | 18 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 7 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 18 |
| 8 | PREDNISONE | 15 |
| 9 | CARBOPLATIN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPICILLIN AND SULBACTAM | 9 | 0.0102 |
| 1 | MILRINONE LACTATE | 1 | 0.0036 |
| 2 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 9 | 0.0035 |
| 3 | PENICILLIN G BENZATHINE | 4 | 0.0029 |
| 4 | THIOGUANINE | 6 | 0.0028 |
| 5 | IBRITUMOMAB TIUXETAN | 4 | 0.0026 |
| 6 | PALIFERMIN | 1 | 0.0026 |
| 7 | AMIFOSTINE | 2 | 0.0025 |
| 8 | BETAXOLOL | 2 | 0.0024 |
| 9 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 48 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 28 |
| 4 | Platinum-based Drug [EPC] | 28 |
| 5 | Azole Antifungal [EPC] | 26 |
| 6 | Alkylating Drug [EPC] | 24 |
| 7 | Loop Diuretic [EPC] | 24 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 18 |
| 9 | Sulfonamide Antimicrobial [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Polyene Antifungal [EPC] | 14 | 0.0003 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 5 | Bile Acid [EPC] | 7 | 0.0003 |
| 6 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 7 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 13 | 0.0002 |
| 9 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |